Breast cancer is classified into several categories based on where it begins in the breast, how far it has grown or spread, and how it behaves. The type of breast cancer you have will help you and your doctor choose the best treatment choices for you.
Breast cancer is classified into several categories based on where it begins to form in the breast, how much it has grown or spread, and specific characteristics that determine how the disease behaves.
The type of breast cancer you have will help you and your doctor choose the best treatment choices for you from oncology hospitals in Hyderabad. In addition, you may read about the many forms of breast cancer in oncology hospitals in Hyderabad, molecular subtypes of breast cancer, and male breast cancer here.
DCIS is the most frequent noninvasive breast cancer, with around 60,000 new cases identified each year in the United States. One out of every five new instances of breast cancer is ductal carcinoma in situ.
Breast cancer of this type is non-invasive, also known as intraductal carcinoma or stage 0 cancer. During DCIS, malignant and aberrant cells, such as the lymph nodes, do not spread from the ducts to neighboring breast tissue or externally, such as the lymph nodes.
DCIS is classified into different subgroups based on the appearance of the tumor. Some subtypes are micropapillary, papillary, solid, cribriform, and comedo.
Ductal carcinoma can sometimes progress to invasive cancer. It may then spread to other regions of the body, such as the bones and distant organs, a process known as metastasis. The Cancerous cells spread through the lymph system (part of the immune system) or the circulation.
According to the American Cancer Society, invasive ductal carcinoma accounts for about eight out of ten breast cancers. Surgery is usually the initial line of therapy for IDC. This therapy aims to remove cancer from the breast by a lumpectomy or mastectomy.
This type of breast cancer is aggressive, lacking additional HER2 proteins and testing negative for estrogen and progesterone receptors. Invasive breast cancers with triple-negative results account for approximately 12% of all cases in a cancer treatment hospital in Hyderabad.
LCIS is not technically cancer but rather an alteration in the breast. Tens of thousands of small clusters of lobules generate breast milk in the breast. Inside these lobules, cancer-like cells may proliferate. LCIS tends to stay put and not spread. However, because LCIS increases your risk of invasive breast cancer, your care team may wish to watch you in order to treat any changes as soon as possible.
Inflammatory breast cancer is an uncommon and deadly form of invasive breast cancer. Inflammatory breast cancer accounts for around 1% of all breast cancers in the United States.
The Invasive type of breast cancer which immediately spreads to other parts of the body, such as the liver, bones, lungs, or brain, is known as metastatic breast cancer.
Breast cancer can reappear in another section of the body months or years after treatment (this is known as a metastatic recurrence), but some patients are first diagnosed with it.
Surgery and radiation therapy are localized treatments available at oncology hospitals in Hyderabad for invasive lobular carcinoma and systemic treatments. No matter what type of treatment a patient undergoes, it is important to keep a positive attitude. It is the positive energy within the patient that can lead to the success of any treatment.
